Skip to main content
Anna Chalmers
Rating: 4.9 of 5
( out of 95 reviews )

Anna Chalmers, MD

Languages spoken: English

Clinical Locations

Primary Location

Sugar House Health Center

1280 E. Stringham Avenue
Salt Lake City , UT 84106
  • Anna Chalmers, M.D. is an Associate Professor in Division of Oncology and an investigator at the Huntsman Cancer Institute. Dr. Chalmers is a specialist in adult medical oncology, with a focus in sarcoma. She joined the faculty in 2016 and see patients at the Huntsman Cancer Institute in Salt Lake City and Sugarhouse.

    Dr. Chalmers received her bachelor’s degree from Dartmouth College and her medical degree from Drexel University College of Medicine. She completed her residency in Internal Medicine and fellowship in Hematology and Medical Oncology at Rush University Medical Center in Chicago.

    Dr. Chalmers is actively involved in research. She is committed to utilizing clinical studies to benefit her patients at the Huntsman Cancer Institute. She is a member of several international organizations, including the Connective Tissue Oncology Society and the American Society of Clinical Oncology.

    Dr. Chalmers is a native of Newport Beach, California. She enjoys hiking, sailing, and skiing with her children and husband, who is an orthopedic surgeon at the University of Utah.

    Specialties

    Board Certification

    American Board of Internal Medicine
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)

    Patient Rating

    Rating: 4.9 out of 5
    4.9 /5
    ( out of 95 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    December 27, 2025
    SUGAR HOUSE HEALTH CENTER
    Rating: 4 out of 5

    Cordial

    October 25, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    She is the best doctor [TRANSLATED]

    October 23, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Absolutely amazing. She walks you through everything patiently and explains things well. She answers questions and takes time to talk to you.

    October 15, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Very caring and knowledgeable.

    October 02, 2025
    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    From the onset of meeting Dr. Chalmers, she was very personable, kind, genuinely concerned & very attentive to my illness. Aside from her being a great specialist, she's more than a Dr treating you. She's very personable & truly cares, taking as much time needed to explain & address your concerns. I wish I lived closer, she's the kind of Dr one prays for when having cancer. I'm thankful to not only her, but our Holy Creator got putting my care in her hands.

    September 11, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    She's the best, everyone says the same thing. [TRANSLATED]

    September 05, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Dr Chalmers is always caring and compassionate. She listens and understands my concerns.

    August 24, 2025
    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    I really like her. She is knowledgeable and cared about me and my health! She took the time to talk to me, my husband and daughter and we felt comfortable and she didn't appear rushed even though we know she is a very busy doctor. I completely trust her to help us make good decisions for my health.

    August 18, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Excellent Doctor [TRANSLATED]

  • Anna Chalmers, M.D. is an Associate Professor in Division of Oncology and an investigator at the Huntsman Cancer Institute. Dr. Chalmers is a specialist in adult medical oncology, with a focus in sarcoma. She joined the faculty in 2016 and see patients at the Huntsman Cancer Institute in Salt Lake City and Sugarhouse.

    Dr. Chalmers received her bachelor’s degree from Dartmouth College and her medical degree from Drexel University College of Medicine. She completed her residency in Internal Medicine and fellowship in Hematology and Medical Oncology at Rush University Medical Center in Chicago.

    Dr. Chalmers is actively involved in research. She is committed to utilizing clinical studies to benefit her patients at the Huntsman Cancer Institute. She is a member of several international organizations, including the Connective Tissue Oncology Society and the American Society of Clinical Oncology.

    Dr. Chalmers is a native of Newport Beach, California. She enjoys hiking, sailing, and skiing with her children and husband, who is an orthopedic surgeon at the University of Utah.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Associate Professor (Clinical)
    Academic Divisions Oncology
    Board Certification
    American Board of Internal Medicine
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)

    Education history

    Fellowship Hematology and Medical Oncology - Rush University Medical Center Fellow
    Residency Internal Medicine - Rush University Medical Center Resident
    Professional Medical Medicine - Drexel University College of Medicine M.D.
    Undergraduate Dartmouth College B.A.

    Selected Publications

    Journal Article

    1. Puri S, Malani R, Chalmers A, Kerrigan K, Patel SB, Monynahan K, Cannon L, Blouw B, Akerley W (2023). Keeping a track on leptomeningeal disease in non-small cell lung cancer: A single-institution experience with CNSide(TM). Neurooncol Adv, 6(1), vdad150. (Read full publication)
    2. Kerrigan K, Patel SB, Haaland B, Ose D, Weinberg Chalmers A, Haydell T, Meropol NJ, Akerley W (2020). Prognostic Significance of Patient-Reported Outcomes in Cancer. JCO Oncol Pract, 16(4), e313-e323. (Read full publication)
    3. Chalmers AW, Patel S, Boucher K, Cannon L, Esplin M, Luckart J, Graves N, Van Duren T, Akerley W (2019). Phase I Trial of Targeted EGFR or ALK Therapy with Ipilimumab in Metastatic NSCLC with Long-Term Follow-Up. Target Oncol, 14(4), 417-421. (Read full publication)
    4. Chalmers A, Cannon L, Akerley W (2018). Adverse Event Management in Patients with BRAF V600E-Mutant Non-Small Cell Lung Cancer Treated with Dabrafenib plus Trametinib. Oncologist, 24(7), 963-972. (Read full publication)

    Editorial

    1. Chalmers AW, Patel SB, Akerley W (2018). Immunotherapy after chemoradiotherapy in stage III non-small cell lung cancer: a new standard of care? J Thorac Dis, 10(3), 1198-1200. (Read full publication)

    Letter

    1. Chalmers A, Akerley W (2017). Retrospective, Multi-Institutional Analysis of Sequential Treatment of Brain Metastases in Treatment-Naïve, Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer Should Not Define the Standard of Practice. [Letter to the editor]. J Clin Oncol, 35(20), 2340. (Read full publication)

    Abstract

    1. Chia Jie Tan1, Connor Willis1, Timothy Bell2, Brad Tumminello2, ShengfanZhou2, Dipam Doshi2, Carl Asche1, Joe Biskuspiak1, Diana Brixner1, Anna Chalmers3, David Stenehjem (). DEVELOPMENT OF AN ALGORITHM TO IDENTIFY PATIENTS (PT) WITH DESMOID TUMORS (DT) IN A UNITED STATES (US) CLAIMS DATASET [Abstract]. (Epub ahead of print)
    2. Sandra P DAngelo1, Dejka M Araujo2, Albiruni RA Razak3, Andrew JS Furness4, Brian AVan Tine5, Mihaela Druta6, Melissa A Burgess7, Fiona Thistlethwaite8, Anna W Chalmers9, John B Haanen10, Jonathan Noujaim11, Richard F Riedel12, David A Liebner13, Neeta Somaiah2, Warren A Chow14, Rashmi Chugh15, Lara E Davis16, Ana Sebio17, Mark Agulnik18, Edouard Forcade19, Michael J Wagner20, Stephan A Grupp21, Scott M Schuetze22, Michael Carlton23, Beth Ireland23, Erin Van Winkle24, Michael J Nathenson24, Dennis Williams24, Elliot Norry24, John W Glod2 (2025). INTEGRATED EFFICACY AND SAFETY ANALYSIS OF LETETRESGENE AUTOLEUCEL, A T-CELL RECEPTOR T-CELL THERAPY, ACROSS CLINICAL TRIALS OF PATIENTS WITH SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA [Abstract].